| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 地胆草内酯B; Elephscabertopin B | CFN95734 | 2522820-34-2 | C19H20O7 = 360.4 | 5mg | QQ客服：3257982914 |
| Elephantopinolide D; Elephantopinolide D | CFN95735 | 2522817-71-4 | C20H22O7 = 374.4 | 5mg | QQ客服：2056216494 |
| alpha-Santalen-12-oic acid; alpha-Santalen-12-oic acid | CFN95743 | 74642-79-8 | C15H22O2 = 234.3 | 20mg | QQ客服：2159513211 |
| Dolichovespulide; Dolichovespulide | CFN95760 | 2368827-42-1 | C15H20O5 = 280.3 | 5mg | QQ客服：2159513211 |
| 新化合物37; New compound 37 | CFN95761 | N/A | C15H22O3 = 250.3 | 5mg | QQ客服：2056216494 |
| 新化合物38; New compound 38 | CFN95762 | N/A | C15H22O3 = 250.3 | 5mg | QQ客服：1457312923 |
| 帝王龙涎; Ambrocenide | CFN91443 | 211299-54-6 | C18H30O2 = 278.4 | 20mg | QQ客服：3257982914 |
| Strychnistenolide 6-O-acetate; Strychnistenolide 6-O-acetate | CFN95794 | 325969-56-0 | C17H20O5 = 304.3 | 10mg | QQ客服：2056216494 |
| 郁金内酯A; Zedoalactone A | CFN95844 | 170384-82-4 | C15H22O4 = 266.3 | 10mg | QQ客服：1457312923 |
| 郁金内酯C; Zedoalactone C | CFN95847 | 864430-46-6 | C15H22O4 = 266.3 | 10mg | QQ客服：1457312923 |
| 异蓬莪二醇; Isozedoarondiol | CFN95848 | 108887-68-9 | C15H24O3 = 252.4 | 5mg | QQ客服：1413575084 |
| Phaeocaulisin I; Phaeocaulisin I | CFN95856 | 1438899-53-6 | C15H20O4 = 264.3 | 5mg | QQ客服：215959384 |
| Curcuwenol G; Curcuwenol G | CFN95867 | 1190225-67-2 | C15H20O4 = 264.3 | 5mg | QQ客服：2159513211 |
| Curdionolide B; Curdionolide B | CFN95868 | 1190225-68-3 | C15H20O3 = 248.3 | 5mg | QQ客服：1413575084 |
| 郁金内酯F; Zedoalactone F | CFN95882 | N/A | C15H18O3 = 246.3 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)